These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

871 related items for PubMed ID: 16391831

  • 21. Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
    Yang M, Du C, Gong P, Xia F, Sun C, Feng X, Lei L, Song J, Zhang L, Wang B, Xiao F, Yan X, Cui Z, Li X, Gu J, Han W.
    Res Microbiol; 2015 Oct; 166(8):633-43. PubMed ID: 26254772
    [Abstract] [Full Text] [Related]

  • 22. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice.
    Sunagar R, Patil SA, Chandrakanth RK.
    Res Microbiol; 2010 Dec; 161(10):854-60. PubMed ID: 20868746
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY, Yang ZC, Gong YL, Huang GT, Yin SP, Jiang B, Peng YZ.
    Zhonghua Shao Shang Za Zhi; 2016 Sep 20; 32(9):523-8. PubMed ID: 27647067
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
    Blahová J, Králiková K, Krcméry V, Mlynarcík D, Trupl J.
    Acta Virol; 1997 Oct 20; 41(5):293-6. PubMed ID: 9607084
    [Abstract] [Full Text] [Related]

  • 28. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.
    Jado I, López R, García E, Fenoll A, Casal J, García P, Spanish Pneumococcal Infection Study Network.
    J Antimicrob Chemother; 2003 Dec 20; 52(6):967-73. PubMed ID: 14613958
    [Abstract] [Full Text] [Related]

  • 29. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, Coffey A, Ross RP, Hill C.
    mBio; 2012 Dec 20; 3(2):e00029-12. PubMed ID: 22396480
    [Abstract] [Full Text] [Related]

  • 30. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
    Alves DR, Perez-Esteban P, Kot W, Bean JE, Arnot T, Hansen LH, Enright MC, Jenkins AT.
    Microb Biotechnol; 2016 Jan 20; 9(1):61-74. PubMed ID: 26347362
    [Abstract] [Full Text] [Related]

  • 31. An experimental mouse model for phage therapy of bacterial pathogens causing bacteremia.
    Kaabi SAG, Musafer HK.
    Microb Pathog; 2019 Dec 20; 137():103770. PubMed ID: 31586662
    [Abstract] [Full Text] [Related]

  • 32. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
    Abd El-Aziz AM, Elgaml A, Ali YM.
    J Infect Dis; 2019 Apr 16; 219(9):1439-1447. PubMed ID: 30476337
    [Abstract] [Full Text] [Related]

  • 33. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.
    Tiwari BR, Kim S, Rahman M, Kim J.
    J Microbiol; 2011 Dec 16; 49(6):994-9. PubMed ID: 22203564
    [Abstract] [Full Text] [Related]

  • 34. A method for generation phage cocktail with great therapeutic potential.
    Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X.
    PLoS One; 2012 Dec 16; 7(3):e31698. PubMed ID: 22396736
    [Abstract] [Full Text] [Related]

  • 35. Engineered Superinfective Pf Phage Prevents Dissemination of Pseudomonas aeruginosa in a Mouse Burn Model.
    Prokopczuk FI, Im H, Campos-Gomez J, Orihuela CJ, Martínez E.
    mBio; 2023 Jun 27; 14(3):e0047223. PubMed ID: 37039641
    [Abstract] [Full Text] [Related]

  • 36. Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.
    Danis-Wlodarczyk K, Olszak T, Arabski M, Wasik S, Majkowska-Skrobek G, Augustyniak D, Gula G, Briers Y, Jang HB, Vandenheuvel D, Duda KA, Lavigne R, Drulis-Kawa Z.
    PLoS One; 2015 Jun 27; 10(5):e0127603. PubMed ID: 25996839
    [Abstract] [Full Text] [Related]

  • 37. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
    Fujiki J, Furusawa T, Munby M, Kawaguchi C, Matsuda Y, Shiokura Y, Nakamura K, Nakamura T, Sasaki M, Usui M, Iwasaki T, Gondaira S, Higuchi H, Sawa H, Tamura Y, Iwano H.
    Microbiol Immunol; 2020 Nov 27; 64(11):778-782. PubMed ID: 32918505
    [Abstract] [Full Text] [Related]

  • 38. Isolation and Characterization of Bacteriophages Active against Pseudomonas aeruginosa Strains Isolated from Diabetic Foot Infections.
    Mohamed WF, Askora AA, Mahdy MMH, El-Hussieny EA, Abu-Shady HM.
    Arch Razi Inst; 2022 Dec 27; 77(6):2187-2200. PubMed ID: 37274914
    [Abstract] [Full Text] [Related]

  • 39. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD, Wolter DJ.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of MDR-specific phage Pɸ-Mi-Pa loaded mucoadhesive electrospun nanofibrous scaffolds against drug-resistant Pseudomonas aeruginosa- induced wound infections in an animal model.
    Ilomuanya MO, Oseni BA, Okwuba BC, Abia P, Aboh MI, Oluwale OP, Alkiviadis T, Tsouknidas AE, Amenaghawon AN, Nwaneri SC.
    Int J Biol Macromol; 2024 Oct 15; 277(Pt 3):134484. PubMed ID: 39102904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.